CN103687585B - 美白剂及黑素生成抑制剂 - Google Patents
美白剂及黑素生成抑制剂 Download PDFInfo
- Publication number
- CN103687585B CN103687585B CN201280017155.5A CN201280017155A CN103687585B CN 103687585 B CN103687585 B CN 103687585B CN 201280017155 A CN201280017155 A CN 201280017155A CN 103687585 B CN103687585 B CN 103687585B
- Authority
- CN
- China
- Prior art keywords
- chafurosideb
- whitening agent
- agent
- melanogenesis
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 31
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 26
- 230000003061 melanogenesis Effects 0.000 title claims abstract description 25
- 239000003112 inhibitor Substances 0.000 title claims abstract description 16
- 239000004615 ingredient Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 4
- 229930003944 flavone Natural products 0.000 claims description 4
- 150000002212 flavone derivatives Chemical class 0.000 claims description 4
- 235000011949 flavones Nutrition 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 claims description 4
- 150000002338 glycosides Chemical class 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 4
- 229930185379 chafuroside Natural products 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 210000002752 melanocyte Anatomy 0.000 description 16
- 244000269722 Thea sinensis Species 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 235000013616 tea Nutrition 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 11
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 10
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 10
- 238000013329 compounding Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 5
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 5
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 5
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 235000020333 oolong tea Nutrition 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000209051 Saccharum Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000015168 fish fingers Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000003574 melanophore Anatomy 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- -1 sucrose fatty acid ester Chemical class 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 238000011765 DBA/2 mouse Methods 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000014651 chocolate spreads Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000019503 curry powder Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003101 melanogenic effect Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 229940032039 pummelo extract Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000438 stratum basale Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供一种具有优异的美白作用及黑素生成抑制作用、且作为美白剂及黑素生成抑制剂有用的化合物。本发明的美白剂及黑素生成抑制剂的特征在于其包含Chafuroside？B。
Description
相关申请
本申请主张2011年4月12日申请的日本国专利申请2011-88317号的优先权，将其包含在内。
技术领域
本发明涉及一种美白剂及黑素生成抑制剂，特别是涉及其有效成分。
背景技术
一般认为皮肤的斑点、雀斑等色素沉积是以激素异常或紫外线、皮肤局部炎症为原因而导致过量形成黑素、并使该黑素沉积在皮肤内而产生的。成为皮肤色素沉积的原因的该黑素在位于表皮基底层的色素细胞(黑素细胞)内的被称为黑素体的细胞器内生成，生成的黑素被摄入至周围角化细胞(角化细胞)。
作为预防、改善如上所述的色素沉积的方法，主要使用具有美白作用的物质、即抑制黑素生成的物质。作为色素沉积的预防、改善方法，公知有例如：大量口服维他命C的方法、注射谷胱甘肽等的方法、或者以软膏、霜膏、洗液等的形式在皮肤上局部涂布曲酸、维他命C及其衍生物、半胱氨酸等的方法等。
另一方面，Chafuroside(チャフロサィド)为一种可以通过由乌龙茶等的茶萃取而分离的化合物。该Chafuroside对过敏性疾病有效，已知有得到以高比例包含该Chafuroside的茶叶的方法(专利文献1)。但是，没有关于ChafurosideB的美白效果、黑素生成抑制效果的报告。
现有技术文献
专利文献
专利文献1：日本特开2009-131161号公报
发明内容
发明所要解决的课题
本发明是鉴于所述现有技术而进行的，其想要解决的课题在于提供一种具有优异的美白作用、黑素生成抑制作用，且作为美白剂及黑素生成抑制剂有用的化合物。
用于解决课题的手段
本发明人等为了解决所述课题而潜心研究，结果发现ChafurosideB具有优异的美白作用及黑素生成抑制作用，从而完成了本发明。
即，本发明的美白剂，其特征在于，包含ChafurosideB。
本发明的黑素生成抑制剂，其特征在于，包含ChafurosideB。
本发明的黑素生成抑制方法，其特征在于，将包含有效量的ChafurosideB的组合物经口服施与。
另外，本发明的黑素生成抑制方法，其特征在于，将包含有效量的ChafurosideB的组合物涂布在皮肤上。
在所述黑素生成抑制方法中，优选ChafurosideB作为美白剂发挥功能。
ChafurosideB的使用，其中，ChafurosideB在以包含ChafurosideB为特征的本发明的美白剂的制造中作为有效成分而使用。
在所述使用中，优选所述ChafurosideB抑制黑素的生成。
发明的效果
本发明的美白剂及黑素生成抑制剂可以提供一种包含ChafurosideB且美白作用及黑素生成抑制作用优异的制剂。
附图的说明
图1为验证牡荆素、异牡荆黄素和ChafurosideB对于UVB表皮黑素细胞活化的效果的图。
图2为表示ChafurosideA及ChafurosideB对于UVB表皮黑素细胞活化的效果的图。
具体实施方式
本发明的美白剂及黑素生成抑制剂包含ChafurosideB。ChafurosideB为由下式(I)所示的黄酮C糖苷。
[化学式1]
ChafurosideB的制造方法没有特别限定，可以使用通过公知的方法所合成的合成品，也可以通过公知的纯化方法由绿茶、焙茶、红茶、乌龙茶等的茶叶进行分离。
在口服包含美白剂及黑素生成抑制剂的有效成分、即ChafurosideB的组合物的情况下，优选服用有效量的ChafurosideB。ChafurosideB优选每一天服用0.001mg／kgb.w.以上。另外，特别优选每一天服用1mg／kgb.w.以上。
本发明的美白剂及黑素生成抑制剂也可以配混在美白用饮料或者美白用食品中。美白用饮料或美白用食品中，除作为有效成分的ChafurosideB之外，还可以根据需要任意选择添加剂并配混。作为添加剂，可以举出：赋形剂、呈味剂、着色剂、保存剂、增稠剂、稳定剂、凝胶化剂、抗氧化剂、功能性材料等。
作为功能性材料，可以举出：各种维他命类、泛酸、叶酸、生物素、锌、钙、镁、氨基酸、寡糖、蜂胶、蜂王浆、EPA、DHA、辅酶Ｑ10、软骨素、乳酸菌、乳铁蛋白、异黄酮、梅干、甲壳质、壳聚糖、氨基葡萄糖等。
作为赋形剂，只要为制作所需剂型时通常所使用的物质则没有限定，例如，可以举出：如二氧化硅微粒之类的粉末类、蔗糖脂肪酸酯、结晶纤维素／羧甲基纤维素钠、磷酸氢钙、小麦淀粉、大米淀粉、玉米淀粉、马铃薯淀粉、糊精、环糊精等淀粉类、结晶纤维素类、乳糖、葡萄糖、砂糖、还原麦芽糖、糖浆、果寡糖、乳化寡糖等糖类、山梨糖醇、赤藓糖醇、木糖醇、乳糖醇、甘露醇等糖醇类等。
作为呈味剂，可以举出：作为果汁提取物的文旦提取物、荔枝提取物、苹果果汁、橘子汁、柚子萃取物、桃子香精、梅子香精、作为甜味剂的安赛蜜K、赤藓糖醇、寡糖类、甘露糖、木糖醇、异构化糖类、作为茶成分的绿茶、乌龙茶、巴拿巴茶、杜仲茶、铁观音茶、薏仁茶、绞股蓝茶、茭白茶、昆布茶、酸奶香精等。
着色剂、保存剂、增稠剂、稳定剂、凝胶化剂、抗氧化剂可以适当选择用于食物和饮料的公知的物质。
作为本发明的美白剂及黑素生成抑制剂的形态，可以制成安瓿剂、胶囊、丸剂、片剂、粉末、颗粒、固形、液体、凝胶或气泡、霜膏等任意形态。
具体而言，例如，可以举出：美容·健康饮料或食品、医药品、西点类、和糕点类、口香糖、糖果、焦糖等一般糕点类、果汁等一般清凉饮料水、鱼糕、圆筒状鱼糕等加工水产糊状产品、香肠、火腿等畜产产品、鲜面条、煮面、荞麦面等面类、调味汁、酱油、调味酱、砂糖、蜂蜜、糖粉、糖浆等调料、咖喱粉、芥末粉、胡椒粉等的香辣佐料、果酱、橘子酱、巧克力酱、奶酪、黄油、酸奶等乳制品等。为了可高效地摄取，可以优选举出：口服的美容／健康饮料、美容／健康食品等。
另外，它们可以通过现有公知的方法来制造。
应予说明，本发明的美白剂及黑素生成抑制剂期待透皮吸收的效果，也可以配混在皮肤外用剂等的组合物中。作为皮肤外用剂的形式，可以举出：化妆品、贴剂、医药品等。
在皮肤外用剂中，除作为有效成分的ChafurosideB以外，也可以根据需要适当配混通常用于化妆品或医药品等皮肤外用剂中的成分，例如：保湿剂、抗氧化剂、油性成分、紫外线吸收剂、表面活性剂、增稠剂、醇类、粉末成分、色剂、水性成分、水、各种皮肤营养剂等。
在包含本发明的美白剂的皮肤外用剂中，优选配混有效量的ChafurosideB。就ChafurosideB的配混量而言，在皮肤外用剂总量中，特别优选为0.001～5.0质量％。如配混量过少，则不能充分发挥美白效果，即使配混量过多，也并没有大的效果的提高，故不优选。
实施例
下面列举实施例对本发明进而进行详细说明，但本发明不受其限定。
作为下面的试验中所使用的动物，使用雄性DBA／2小鼠(日本CharlesRiver公司)。购买5周龄的小鼠，驯化饲养一周后使用。
另外，让小鼠自由摄取灭菌蒸馏水及饲料AIN-93G(日本农产工业公司)。
牡荆素、异牡荆黄素使用市售品(SIGMA-ALDRICH公司)，ChafurosideB通过公知的方法(J.Agric.FoodChem.2009，57，6779-6786)由茶分离。然后，使用上述动物，通过下述试验方法进行黑素细胞活化抑制试验。
应予说明，牡荆素、异牡荆黄素分别与ChafurosideB一样为在茶中包含的黄酮类。
·黑素细胞活化抑制试验方法
使用包含牡荆素或异牡荆黄素或ChafurosideB(1mg／kgb.w.)的介质对小鼠经口进行灌胃9天，施与后照射照射量为120mJ的中波长紫外线（UVB)。对照(UV非照射组）及对照(UV照射组)同样施与介质。应予说明，各组各以8只小鼠进行试验。
在本试验中，就介质及其施与用量而言，以0.5w／v％甲基纤维素400溶液、5mL／kgb.w.进行。
第10天采集皮肤，进行DOPA反应。在显微镜观察下，计算单位面积的DOPA阳性黑素细胞数。
将结果示于图1。应予说明，图中的＊表示在通过学生t检验(显著性水平＊p<0.05、＊＊p<0.01)进行统计处理的情况下，相对于对照(UV照射组）确认有显著差异。
根据图1，作为与ChafurosideB具有类似结构的黄酮类的牡荆素虽然具有抑制黑素细胞数增加的倾向，但未显著抑制。另外，作为与ChafurosideA具有类似结构的黄酮类的异牡荆黄素显著抑制黑素细胞数的增加。
但是，令人惊讶的是，ChafurosideB非常显著地抑制黑素细胞数的增加。
接着，本发明人等将ChafurosideA及ChafurosideB作为样品，与上述试验方法相同地进行了黑素细胞活化抑制试验。将结果示于图2。
根据图2，确认通过UV照射，DOPA阳性黑素细胞数显著增加(UV照射组)。ChafurosideA及ChafurosideB显著抑制黑素细胞数的增加。但是，与ChafurosideA相比，可以明确ChafurosideB更为明显地抑制黑素细胞数的增加。
因此，本发明的美白剂及黑素生成抑制剂的特征在于，包含ChafurosideB。
下面，列举本发明的美白剂及黑素生成抑制剂、即ChafurosideB的配混例。但本发明不受其限定。
配混例1颗粒
配混例2乳液
Claims (4)
1.ChafurosideB的用于制造美白剂的使用，其特征在于，ChafurosideB为下式(I)所示的黄酮C糖苷，
[化学式1]
2.ChafurosideB的用于制造黑素生成抑制剂的使用，其特征在于，ChafurosideB为下式(I)所示的黄酮C糖苷、即，
[化学式1]
3.下式(I)所示的黄酮C糖苷、即ChafurosideB的使用，其中，ChafurosideB在以包含ChafurosideB为特征的美白剂的制造中作为有效成分而使用，
[化学式1]
4.根据权利要求3所述的使用，其特征在于，所述ChafurosideB抑制黑素生成。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011-088317 | 2011-04-12 | ||
| JP2011088317 | 2011-04-12 | ||
| PCT/JP2012/060046 WO2012141255A1 (ja) | 2011-04-12 | 2012-04-12 | 美白剤およびメラニン生成抑制剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103687585A CN103687585A (zh) | 2014-03-26 |
| CN103687585B true CN103687585B (zh) | 2015-11-25 |
Family
ID=47009422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280017155.5A Expired - Fee Related CN103687585B (zh) | 2011-04-12 | 2012-04-12 | 美白剂及黑素生成抑制剂 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5162727B2 (zh) |
| CN (1) | CN103687585B (zh) |
| HK (1) | HK1196096A1 (zh) |
| TW (1) | TWI566772B (zh) |
| WO (1) | WO2012141255A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012219076A (ja) * | 2011-04-12 | 2012-11-12 | Shizuokaken Koritsu Daigaku Hojin | 美白剤およびメラニン生成抑制剤 |
| JP7001356B2 (ja) * | 2016-03-31 | 2022-01-19 | 小林製薬株式会社 | 皮膚色素沈着抑制剤 |
| CN110464669A (zh) * | 2019-08-16 | 2019-11-19 | 香港科技大学深圳研究院 | 一种美白剂及其用途、美白用化妆品和美白用医药产品 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1671713A (zh) * | 2002-07-03 | 2005-09-21 | 三得利株式会社 | 黄酮c糖苷的新型衍生物和含有其的组合物 |
| CN1938318A (zh) * | 2004-03-31 | 2007-03-28 | 三得利株式会社 | 黄酮c糖苷衍生物的制造方法 |
| CN101938988A (zh) * | 2008-02-08 | 2011-01-05 | 株式会社资生堂 | 美白剂和皮肤外用剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11228339A (ja) * | 1998-02-13 | 1999-08-24 | Ichimaru Pharcos Co Ltd | メラニン生成抑制剤及び皮膚外用剤 |
| BR0312137A (pt) * | 2002-06-12 | 2005-04-05 | Mcw Res Found Inc | Processo de tratamento de dano de reperfusão de isquemia usando antagonistas de receptor de adenosina |
| JP2006008626A (ja) * | 2004-06-28 | 2006-01-12 | Daiichi Asubio Pharma Co Ltd | フラボン誘導体の製造法ならびにフラボン誘導体およびそれを含む医薬組成物 |
| JP2006342103A (ja) * | 2005-06-09 | 2006-12-21 | National Cancer Center-Japan | ウーロン茶葉抽出物ｏｔａｃを有効成分とする発癌抑制剤 |
| TW200817039A (en) * | 2006-10-06 | 2008-04-16 | Dynamis Therapeutics Inc | Compositions and methods for skin lightening |
| JP5226982B2 (ja) * | 2007-08-06 | 2013-07-03 | 全薬工業株式会社 | ソバガラの抽出物を含む皮膚外用剤 |
| JP5597142B2 (ja) * | 2009-01-03 | 2014-10-01 | 静岡県公立大学法人 | 硫酸化ｃ−配糖体及びその単離方法並びに合成方法 |
-
2012
- 2012-04-12 WO PCT/JP2012/060046 patent/WO2012141255A1/ja active Application Filing
- 2012-04-12 TW TW101112953A patent/TWI566772B/zh not_active IP Right Cessation
- 2012-04-12 CN CN201280017155.5A patent/CN103687585B/zh not_active Expired - Fee Related
- 2012-04-12 JP JP2012533157A patent/JP5162727B2/ja active Active
-
2014
- 2014-09-24 HK HK14109579.4A patent/HK1196096A1/zh not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1671713A (zh) * | 2002-07-03 | 2005-09-21 | 三得利株式会社 | 黄酮c糖苷的新型衍生物和含有其的组合物 |
| CN1938318A (zh) * | 2004-03-31 | 2007-03-28 | 三得利株式会社 | 黄酮c糖苷衍生物的制造方法 |
| CN101938988A (zh) * | 2008-02-08 | 2011-01-05 | 株式会社资生堂 | 美白剂和皮肤外用剂 |
Non-Patent Citations (2)
| Title |
|---|
| Concise Synthesis of Chafurosides A and B;Takumi Furuta，等;《ORGANIC LETTERS》;20090427;第11卷(第11期);第2233-2236页 * |
| Quantitation of Chafurosides A and B in Tea Leaves and Isolation of Prechafurosides A and B from Oolong Tea Leaves;HITOSHI ISHIDA，等;《JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY》;20091231;第57卷(第15期);第6779-6786页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2012141255A1 (ja) | 2014-07-28 |
| CN103687585A (zh) | 2014-03-26 |
| WO2012141255A1 (ja) | 2012-10-18 |
| TWI566772B (zh) | 2017-01-21 |
| HK1196096A1 (zh) | 2014-12-05 |
| JP5162727B2 (ja) | 2013-03-13 |
| TW201247197A (en) | 2012-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5654731B2 (ja) | 藍草抽出物粉末とその製造方法及びその藍草抽出物粉末の用途 | |
| JP2002293736A (ja) | メーラード反応阻害剤およびそれを含有する組成物 | |
| JP2010053122A (ja) | 脂質合成阻害剤 | |
| KR101320738B1 (ko) | 미세조류 유래 색소를 추출하는 방법 및 추출된 푸코크산틴을 포함하는 비만 또는 당뇨의 예방 또는 치료용 조성물 | |
| JP4363841B2 (ja) | ポリフェノールの水に対する溶解性の改善方法ならびにポリフェノール高含有水溶液 | |
| CN103687585B (zh) | 美白剂及黑素生成抑制剂 | |
| KR101474998B1 (ko) | 피부 주름 생성 억제 및 주름 개선 활성을 갖는 백차 추출물을 함유하는 조성물 | |
| JP2010265215A (ja) | メチオニナーゼ阻害剤 | |
| JP2006306804A (ja) | シワ形成抑制剤 | |
| JP5969529B2 (ja) | 抗炎症剤 | |
| KR102118866B1 (ko) | 식물 추출물의 혼합물을 유효성분으로 함유하는 항비만 및 셀룰라이트 감소용 조성물 | |
| JP6021842B2 (ja) | ブラックジンジャー抽出物組成物及びブラックジンジャー抽出物含有飲食物並びにブラックジンジャー抽出物の呈味改善方法 | |
| JP6718158B2 (ja) | 肝機能改善剤 | |
| JP2010037221A (ja) | アディポネクチン産生増強剤 | |
| JP2019073476A (ja) | Ａｔｐ産生促進用剤 | |
| JP2002047193A (ja) | アレルギー性皮膚炎予防または治療用組成物 | |
| JP7130900B2 (ja) | 組成物 | |
| JP7320270B2 (ja) | 肝機能改善剤 | |
| JP5536913B2 (ja) | 血小板凝集抑制剤 | |
| JP2012219076A (ja) | 美白剤およびメラニン生成抑制剤 | |
| JP7359415B2 (ja) | ウレアーゼ阻害剤 | |
| JP2009108050A (ja) | 治療剤 | |
| JP2012077063A (ja) | 美白剤 | |
| JP2023074268A (ja) | ＩＬ－１α発現抑制剤 | |
| JP2023059099A (ja) | マイオネクチン産生促進剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1196096 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1196096 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151125 |